Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, $0.0001 Par Value
-
Shares outstanding
-
9,614,000
-
Total 13F shares
-
21,510,354
-
Share change
-
-159,091
-
Total reported value
-
$733,206,641
-
Price per share
-
$34.25
-
Number of holders
-
69
-
Value change
-
+$28,950,630
-
Number of buys
-
48
-
Number of sells
-
31
Institutional Holders of Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) as of Q4 2020
As of 31 Dec 2020,
Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) was held by
69 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,510,354 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, RTW INVESTMENTS, LP, VIKING GLOBAL INVESTORS LP, VR Adviser, LLC, CITADEL ADVISORS LLC, Avidity Partners Management LP, JANUS HENDERSON GROUP PLC, Logos Global Management LP, BlackRock Inc., and Rock Springs Capital Management LP.
This page lists
69
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.